Company Filing History:
Years Active: 2017
Title: The Innovations of Pascal Andre Rene Benderitter
Introduction
Pascal Andre Rene Benderitter is a notable inventor based in Apollinaire, France. He has made significant contributions to the field of biotechnology, particularly in the development of kinase inhibitors. His work focuses on creating innovative solutions for diseases associated with SIK kinases.
Latest Patents
Benderitter holds a patent for "Macrocyclic salt-inducible kinase inhibitors." This invention relates to macrocyclic compounds and compositions that act as kinase inhibitors, specifically targeting SIK kinases such as SIK1, SIK2, and SIK3. The patent outlines methods for using these compounds in the diagnosis, prevention, and treatment of diseases associated with SIK kinases. This advancement has the potential to impact medical treatments significantly.
Career Highlights
Benderitter is currently associated with Oncodesign SA, a company that specializes in drug discovery and development. His role at Oncodesign has allowed him to further his research and contribute to innovative solutions in the field of oncology and other related areas.
Collaborations
Benderitter has collaborated with notable colleagues, including Petra Marcella Francoise Blom and Jan Marie Cyriel Jozef Hoflack. These collaborations have fostered a productive environment for research and development, enhancing the impact of their collective work.
Conclusion
Pascal Andre Rene Benderitter's contributions to the field of kinase inhibitors exemplify the importance of innovation in biotechnology. His patent and ongoing work at Oncodesign SA highlight his commitment to advancing medical science and improving treatment options for patients.